Generation Bio Co. (GBIO)
NASDAQ: GBIO · IEX Real-Time Price · USD
2.880
+0.060 (2.13%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $191.60 million as of July 22, 2024. Its market cap has decreased by -42.24% in one year.
Market Cap
191.60M
Enterprise Value
66.06M
1-Year Change
-42.24%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.09B to $191.60M, a decrease of -82.41%. That is a compound annual growth rate of -34.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 191.60M | 75.78% |
| Dec 29, 2023 | 109.00M | -53.32% |
| Dec 30, 2022 | 233.50M | -42.05% |
| Dec 31, 2021 | 402.90M | -69.45% |
| Dec 31, 2020 | 1.32B | 21.09% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 199.96M |
| Renovaro Biosciences | 199.13M |
| P3 Health Partners | 197.60M |
| Trevi Therapeutics | 195.81M |
| ClearPoint Neuro | 193.86M |
| Greenwich LifeSciences | 191.01M |
| G1 Therapeutics | 189.78M |
| EDAP TMS | 189.23M |